Breast and colorectal cancer - expert exchange roundtable summary available
09 Aug 2012
The global burden of cancer continues to increase largely because of the ageing and growth of the world population as well as an increasing adoption of cancer-causing behaviours including smoking, physical inactivity, and ‘‘westernised’’ diets.
According to global cancer statistics, breast cancer in women is the most frequently diagnosed cancer and the leading cause of cancer death in females worldwide. Affecting both men and women, colorectal cancer is the third most common diagnosed cancer in males and the second in females and the second leading cause of death among cancers in the Western world.
Significant improvements in imaging, genetics, molecular profiling, surgical techniques, chemotherapy and targeted therapy are now making significant gains in our ability to prevent, diagnose and treat these serious diseases and will have a notable impact on future breast and colon cancer incidence, morbidity and mortality.
Expert Exchange Roundtable
On the 24th of April 2012, the sixth in the series of Expert Exchange Roundtable (EER) discussions took place to debate the challenges, progress and future directions in breast and colorectal cancer. The presentations by George A. Fisher Jr. and Michael Alvarado covered a wide range of topics from preventive strategies, screening and early detection modalities to selective therapeutic approaches for both diseases. The roundtable was moderated by Florian Rechfeld, medical biochemist in Swiss Re’s Life and Health R&D department.